|
1
|
LaDou J: The asbestos cancer epidemic.
Environ Health Perspect. 112:285–290. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jaurand MC: Mechanisms of fiber-induced
genotoxicity. Environ Health Perspect. 105(Suppl 5): 1073–1084.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Heintz NH, Janssen YM and Mossman BT:
Persistent induction of c-fos and c-jun expression by
asbestos. Proc Natl Acad Sci USA. 90:3299–3303. 1993.PubMed/NCBI
|
|
4
|
Timblin CR, Janssen YW and Mossman BT:
Transcriptional activation of the proto-oncogene c-jun by
asbestos and H2O2is directly related to
increased proliferation and transformation of tracheal epithelial
cells. Cancer Res. 55:2723–2726. 1995.PubMed/NCBI
|
|
5
|
Doll R: Mortality from lung cancer in
asbestos workers. Br J Ind Med. 12:81–86. 1955.
|
|
6
|
Tsuchiya E, Nakamura Y, Weng SY, et al:
Allelotype of non-small cell lung carcinoma - comparison between
loss of heterozygosity in squamous cell carcinoma and
adenocarcinoma. Cancer Res. 52:2478–2481. 1992.PubMed/NCBI
|
|
7
|
Sato S, Nakamura Y and Tsuchiya E:
Difference of allelotype between squamous cell carcinoma and
adenocarcinoma of the lung. Cancer Res. 54:5652–5655.
1994.PubMed/NCBI
|
|
8
|
Hashimoto T, Tokuchi Y, Hayashi M, et al:
Different subtypes of human lung adenocarcinoma caused by different
etiological factors. Evidence from p53 mutational spectra. Am J
Pathol. 157:2133–2141. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vähäkangas K: TP53 mutations in workers
exposed to occupational carcinogens. Hum Mutat. 21:240–251.
2003.PubMed/NCBI
|
|
11
|
Petitjean A, Mathe E, Kato S, et al:
Impact of mutant p53 functional properties on TP53 mutation
patterns and tumor phenotype: lessons from recent developments in
the IARC TP53 database. Hum Mutat. 28:622–629. 2007.PubMed/NCBI
|
|
12
|
Denissenko MF, Pao A, Tang M and Pfeifer
GP: Preferential formation of benzo[a]pyrene adducts at lung
cancer mutational hotspots in P53. Science. 274:430–432.
1996.
|
|
13
|
Smith LE, Denissenko MF, Bennett WP, et
al: Targeting of lung cancer mutational hotspots by polycyclic
aromatic hydrocarbons. J Natl Cancer Inst. 92:803–811. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Japan Lung Cancer Society. General Rules
for Clinical and Pathologic Record of Lung Cancer. 5th edition.
Kanahara, Tokyo: 1999, (In Japanese).
|
|
15
|
Inamura K, Satoh Y, Okumura S, et al:
Pulmonary adenocarcinomas with enteric differentiation: histologic
and immunohistochemical characteristics compared with metastatic
colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg
Pathol. 29:660–665. 2005. View Article : Google Scholar
|
|
16
|
Kohyama N and Suzuki Y: Analysis of
asbestos fibers in lung parenchyma, pleural plaques, and
mesothelioma tissues of North American insulation workers. Ann NY
Acad Sci. 643:27–52. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Greenblatt MS, Bennett WP, Hollstein M and
Harris CC: Mutations in the p53 tumor suppressor gene: clues
to cancer etiology and molecular pathogenesis. Cancer Res.
54:4855–4878. 1994.PubMed/NCBI
|
|
18
|
Nakachi K, Hayashi S, Kawajiri K and Imai
K: Association of cigarette smoking and CYP1A1 polymorphisms
with adenocarcinoma of the lung by grades of differentiation.
Carcinogenesis. 16:2209–2213. 1995.PubMed/NCBI
|
|
19
|
Ninomiya H, Nomura K, Satoh Y, et al:
Genetic instability in lung cancer: concurrent analysis of
chromosomal, mini- and microsatellite instability and loss of
heterozygosity. Br J Cancer. 94:1485–1491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang
NJ and Harris CC: Mutational hotspot in the p53 gene in human
hepatocellular carcinomas. Nature. 350:427–428. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brash DE, Rudolph JA, Simon JA, et al: A
role for sunlight in skin cancer: UV-induced p53 mutations in
squamous cell carcinoma. Proc Natl Acad Sci USA. 88:10124–10128.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Husgafvel-Pursiainen K, Karjalainen A,
Kannio A, et al: Lung cancer and past occupational exposure to
asbestos. Role of p53 and K-ras mutations. Am J
Respir Cell Mol Biol. 20:667–674. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ishikawa Y, Furuta R, Miyoshi T, et al:
Loss of heterozygosity and the smoking index increase with decrease
in differentiation of lung adenocarcinomas: etiologic implications.
Cancer Lett. 187:47–51. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lynch TJ, Bell DW, Sordella R, et al:
Activating mutations in the epidermal growth factor receptor
underlying responsiveness of non-small-cell lung cancer to
gefitinib. N Engl J Med. 350:2129–2139. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Paez JG, Jänne PA, Lee JC, et al:
EGFR mutations in lung cancer: correlation with clinical
response to gefitinib therapy. Science. 304:1497–1500. 2004.
View Article : Google Scholar
|
|
26
|
Soda M, Choi YL, Enomoto M, et al:
Identification of the transforming EML4-ALK fusion gene in
non-small-cell lung cancer. Nature. 448:561–566. 2007.PubMed/NCBI
|
|
27
|
Inamura K and Ishikawa Y: Lung Cancer.
Asian Pacific Organization for Cancer Prevention Cancer Report
2010. Tuncer MA: New Hope in Health Foundation; Turkey: pp.
202–204. 2010
|
|
28
|
Ruosaari ST, Nymark PE, Aavikko MM, et al:
Aberrations of chromosome 19 in asbestos-associated lung cancer and
in asbestos-induced micronuclei of bronchial epithelial cells in
vitro. Carcinogenesis. 29:913–917. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nymark P, Kettunen E, Aavikko M, et al:
Molecular alterations at 9q33.1 and polyploidy in asbestos-related
lung cancer. Clin Cancer Res. 15:468–475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kettunen E, Aavikko M, Nymark P, et al:
DNA copy number loss and allelic imbalance at 2p16 in lung cancer
associated with asbestos exposure. Br J Cancer. 100:1336–1342.
2009. View Article : Google Scholar : PubMed/NCBI
|
